Bill Fleming

Bill Fleming

Chief Financial Officer

Bill’s career spans 30 years in a broad range of finance positions. Holding a law degree from Cambridge University and as a qualified ACMA, Bill has accumulated international FD/CFO experience across start-ups, venture-backed companies, and large multi-nationals.

For the past two decades Bill has focused on healthcare and life sciences serving as European Finance Director for Visible Genetics, a pioneering company in the field of nucleic acid diagnostics, and subsequently holding senior finance positions for Bayer Healthcare in Europe and the USA.

More recently Bill played a leading role in securing investment for Oxford University spinout Oxitec and in its successful acquisition by Intrexon Corporation. Bill is presently a consultant CFO, supporting healthcare start-ups and university spinouts and is chairman of OBN, the leading life sciences network in the UK.